Land: USA
Språk: engelska
Källa: NLM (National Library of Medicine)
Albuterol Sulfate (UNII: 021SEF3731) (Albuterol - UNII:QF8SVZ843E)
Mylan Pharmaceuticals Inc.
Albuterol Sulfate
Albuterol 2.5 mg in 3 mL
RESPIRATORY (INHALATION)
PRESCRIPTION DRUG
Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. Albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. Albuterol Sulfate Inhalation Solution 0.083% 3 Note: This is a unit-dose vial. No dilution is required. Read complete instructions carefully before using. Note: Use only as directed by your physician. More frequent administration or higher doses are not recommended . Store Albuterol Sulfate Inhalation Solution 0.083%3 between 2° and 25° C (36° and 77° F). Store in pouch until time of use. ADDITIONAL INSTRUCTIONS: ___________________________________________ ________________________________________________________________________ ________________________________________________________________________ Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 Manufactured by:
Unit-dose plastic vial containing Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3 mL2. Equivalent to 0.5 mL albuterol (as the sulfate) 0.5% (2.5 mg albuterol) diluted to 3 mL. Supplied in cartons as listed below. NDC 0378-8270-52 25 vials per carton / 25 vials per foil pouch NDC 0378-8270-93 30 vials per carton / 30 vials per foil pouch NDC 0378-8270-91 60 vials per carton / 30 vials per foil pouch NDC 0378-8270-55 30 vials per carton / 1 vial per foil pouch PROTECT FROM LIGHT. Store in pouch until time of use. Store between 2° and 25° C (36° and 77° F).
Abbreviated New Drug Application
ALBUTEROL SULFATE- ALBUTEROL SULFATE SOLUTION MYLAN PHARMACEUTICALS INC. ---------- Albuterol Sulfate Inhalation Solution 0.083% 1 PRESCRIBING INFORMATION FOR INHALATION USE ONLY-NOT FOR INJECTION. DESCRIPTION Albuterol sulfate inhalation solution is a relatively selective beta -adrenergic bronchodilator (see CLINICAL PHARMACOLOGY section below). Albuterol sulfate, the racemic form of albuterol, has the chemical name α -[(_tert_-Butylamino)methyl]-4-hydroxy-_m_-xylene-α,α'-diol sulfate (2:1) (salt), and the following structural formula: Albuterol sulfate has a molecular weight of 576.70, and the molecular formula (C H NO ) • H SO . Albuterol sulfate is a white or practically white powder, freely soluble in water and slightly soluble in alcohol. The World Health Organization recommended name for albuterol base is salbutamol. Albuterol sulfate inhalation solution 0.083% requires no dilution before administration. Each milliliter of Albuterol Sulfate Inhalation Solution 0.083% contains 0.83 mg of albuterol (as 1 mg of albuterol sulfate) in an isotonic, sterile, aqueous solution containing sodium chloride; sulfuric acid is used to adjust the pH to between 3 and 5. Albuterol Sulfate Inhalation Solution 0.083% contains no sulfiting agents or preservatives. Albuterol sulfate inhalation solution is a clear, colorless to light yellow solution. CLINICAL PHARMACOLOGY The prime action of beta-adrenergic drugs is to stimulate adenyl cyclase, the enzyme which catalyzes the formation of cyclic-3',5'-adenosine monophosphate (cyclic AMP) from adenosine triphosphate (ATP). The cyclic AMP thus formed mediates the cellular responses. _In vitro_ studies and _in vivo_ pharmacologic studies have demonstrated that albuterol has a preferential effect on beta -adrenergic receptors compared with isoproterenol. While it is recognized that beta -adrenergic receptors are the predominant receptors in bronchial smooth muscle, 10% to 50% of the beta-receptors in the human heart may be beta -receptors. The precise function of these receptors Läs hela dokumentet